Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pirfenidone as Bridging Therapy for Lung Transplant in Patients Suffering From Idiopathic Pulmonary Fibrosis

NCT03258801 is registered in ClinicalTrials.gov with Dr. Christopher Lambers as lead sponsor.

NCT NCT03258801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03258801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pirfenidone as Bridging Therapy for Lung Transplant in Patients Suffering From Idiopathic Pulmonary Fibrosis
Lead sponsor
Dr. Christopher Lambers
Phase
Observational
Overall status
Withdrawn
Start date
October 29, 2018
Completion date
December 2, 2019
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic pulmonary fibrosis, lung transplant; complications